Factor V Leiden Mutation
The relationship of the factor V Leiden mutation or the deletion deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty
... the Factor V Leiden mutation and the deletion-deletion polymorphism of the angiotensin con- verting enzyme gene were determined for 38 patients who developed symptomatic pulmonary embolism (30 ...
6
Recurrent Pregnancy Loss in a Subject with Heterozygote Factor V Leiden Mutation; a Case Report
... 10. Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med. 2001 Mar-Apr;3(2):139-48. 11. ...
5
Factor V Leiden Mutation and its Impact on Pregnancy Complications
... nancy outcomes such as placental abruption were rare. Eclampsia, intrauterine fetal death and venous thrombo- embolism did not occur. Thromboprophylaxis may have influenced the prevalence of VTE. The incidence of blood ...
5
Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis
... Abstract: A previously healthy 21-year-old man presented with back pain, bilateral extremity pain, and right lower extremity weakness, paresthesias, and swelling. Sonographic examination revealed diffuse deep vein ...
5
Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population
... gene mutation are susceptible to achieve preeclampsia during their next pregnancy more than ...Prothrombin Mutation (FII), Plasminogen activator inhibitor (PAI-1) and also factor V ...
8
Myotonic Dystrophy-1 Complicated by Factor-V (Leiden) Mutation
... a factor-V Leiden mutation in a patient with myotonic dystrophy type 1 (DM1) has been reported only ...a factor-V mutation who died from long-term complications of this ...
5
Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis
... BACKGROUND: Factor V Leiden mutation (Arg506Gln) increases the likelihood of venous thrombosis; it may also have a positive effect through facilitation of embryo ...with factor V ...
5
Down Regulated Protein C Plasma Levels in the Absence of Factor V Leiden Mutation in HIV Patients: An Observational Study in Maiduguri, North Eastern Nigeria
... This study revealed a statistically significant difference in the mean protein C (PC) plasma levels in the control subjects compared to the mean values among patients with HIV. Previous studies had reported such ...
7
Severe hyperhomocysteinemia due to cystathionine β-synthase deficiency, and Factor V Leiden mutation in a patient with recurrent venous thrombosis
... this subgroup the median age at diagnosis was 47 years (range 19-83), and the median level of tHcy was 130 μmol/L (range 101-262). Recurrent thrombosis occurred in 42% of cases [10]. In seven families in a consanguinous ...
5
Factor V Leiden mutation triggering four major complications to standard dose cisplatin-chemotherapy for testicular seminoma: a case report
... Generally, the occurrence of complications secondary to a chemotherapeutic agent is dependent on both the ap- plied dosage of the drug and the predisposition of the individual patient to acquire particular complications. ...
5
Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study
... Immunopurified sheep-anti-human FXIIIA immunoglo- bulin (Ig) G was obtained from Kordia (Leiden, The Netherlands). For western blotting plasma proteins were separated by polyacrylamide SDS gel electrophoreses ...
11
A case series of Factor V Leiden mutation in pregnancy
... Factor V Leiden (FVL) is an autosomal dominantly inherited thrombophilic ...coagulation Factor V (FV), resulting in resistance to inactivation by the activated protein C-protein S ...
5
Relationship between angiotensin I-converting enzyme insertion/deletion gene polymorphism and retinal vein occlusion
... resistance, factor V Leiden mutation, prothrombin 20210 mutation, mean platelet volume, homocysteine, PAI-1 and lipoprotein A ...
6
Lipoprotein (a): Its Role in Childhood Thromboembolism
... the factor V Leiden mutation (DNA prepared from ethylenediamine-tet- raacetic acid blood), factor V, protein C, protein S, antithrombin, and antiphospholipid antibodies ...
5
Factor V Leiden, MTHFR C677T and Prothrombin Gene Mutation G20210A in Iranian Patients with Venous Thrombosis
... the mutation, but also to determine hetero- or homozygosity state of the individuals for the three target ...of Factor V Leiden mutation was ...(C677T) mutation was ...G20210A ...
5
FACTOR 5 LEIDEN STUDY OF GENETIC POLYMORPHISMS AS GENETIC FACTORS THAT CAUSE CARDIOVASCULAR DISEASE IN THE POPULATION OF TABRIZ, IRAN
... the factor V Leiden ...the mutation from a parent (heterozygous) increases by fourfold to eightfold the chance of developing a ...the mutation (homozygous), one from each parent, may ...
29
SURVEY THE MUTATION OF FGB (BETA FIBRINOGEN) AND FV (FACTOR V LEIDEN), FACTOR XIII AND FACTOR II (PROTHROMBIN), IN PATIENTS WITH RECURRENT ABORTIONS ALONG WITH NORMAL KARYOTYPEMaryam Hosseini Moghadam, Pegah Larki, Jafar Panahi, Niloofar Mojtahedifard, Abbas Shakoori*DOWNLOAD/VIEW
... of factor V Leiden mutation was evaluated on 260 women with a history of spontaneous recurrent ...analyzing, mutation of Factor V Leiden was detected in ...of ...
6
Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?
... G20210A mutation in one of our patients and the combination in another ...Prothrombin mutation was detected in ...of factor V Leiden and prothrombin G20210A single nucleotide ...
7
Varicella Purpura Fulminans Associated With Heterozygosity for Factor V Leiden and Transient Protein S Deficiency
... Based on the available case series of varicella- associated purpura fulminans in children, it appears reasonable to evaluate children with any varicella- associated thrombotic event for the presence of pro- tein S and ...
5
Influence of Factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study
... The G1 and ICU cohorts were established prior to the approval of activated protein C (APC) for treatment of severe sepsis. However, cohort G2 and, in part, the IPD cohort were established after 2002. In theory, use of ...
7